V Square Quantitative Management LLC, Cresset Asset Management LLC, Gladstone Capital Management LLP, Point72 Hong Kong Ltd, and others have sizable stock positions in West Pharmaceutical Services, Inc.(WST). Congress Asset Management Co. MA, Schroder Investment Management Group, Northern Trust Corp, and others have sold some of their shares. Despite occasional underperformance compared to competitors, the stock has generally outperformed its competitors on several trading days. The company has reported strong Q2 earnings and revenue and stocks have been bought by reputable companies like American International Group Inc. and Oppenheimer & Co. Inc.. Despite reporting weak annual results and forecasting weak annual results, the company's stock remains a recommended investment due its dividend aristocrat status and it is being portrayed as a solid stock for long-term investors. There also seems to be mixed reporting on insider sales by SVP, Chief Technology Officer Silji Abraham.
West Pharmaceutical Services WST News Analytics from Thu, 27 Jul 2023 07:00:00 GMT to Sun, 16 Jun 2024 09:53:52 GMT -
Rating 6
- Innovation 4
- Information 7
- Rumor -4
